Scientists use AI to identify likely drug targets in search for Alzheimer ' s cure
Scientists use AI to identify likely drug targets in search for Alzheimer's cure
A team led by a University of Arizona College of Medicine – Tucson scientist harnesses artificial intelligence to trace the path from a healthy brain cell to one afflicted by Alzheimer ' s disease.
Anna C. Christensen
Today
College of Medicine – TucsonRui-Chang_khp-web.jpg
Rui Chang, an associate professor of neurology, is leading a team at the College of Medicine – Tucson that uses artificial intelligence to trace the molecular path of the development of Alzheimer's disease.HealthCollege of Medicine - TucsonDeterminationExpertsExploration
Media contact(s)David Bruzzese
College of Medicine – Tucsondbruzzese@arizona.edu520-626-9722Anna Christensen
College of Medicine – Tucsonachristensen@arizona.edu520-626-9964Researchers at the University of Arizona College of Medicine – Tucson, along with collaborators at Harvard University, harnessed the power of artificial intelligence to identify causes of Alzheimer ' s disease and potential drug targets by looking deep into the human brain to map the molecular changes that healthy neurons undergo as the disease progresses. The results are published in Nature Communications Biology.One of medicine ' s most perplexing problems is Alzheimer ' s disease, a neurodegenerative disorder that causes dementia, memory loss, personality changes and other irreversible symptoms. Drugs can treat symptoms of the disease, but finding a cu...
Source: The University of Arizona: Health - Category: Universities & Medical Training Authors: mittank Source Type: research
More News: Alzheimer's | Amnesia | Biology | Brain | Clinical Trials | Computers | Databases & Libraries | Dementia | Food and Drug Administration (FDA) | Genetics | Grants | Harvard | Molecular Biology | National Institutes of Health (NIH) | Neurology | Neuroscience | Partnerships | Science | Stem Cell Therapy | Stem Cells | Study | Universities & Medical Training